自我应用局部干预治疗黄褐斑:随机、研究者盲法临床试验的系统综述与Meta分析
该系统综述与Meta分析检索MEDLINE和Cochrane CENTRAL数据库,纳入36项研究者盲法随机对照试验(共47种干预比较),评估自我应用局部干预治疗黄褐斑的疗效与安全性。结果显示,三联组合霜(TCC)及其成分氢醌(HQ)和维A酸对黄褐斑有提亮效果,广谱防晒(覆盖可见光和紫外线)可增强HQ疗效。由于多数试验样本量小、结局指标差异大,仅两项比较可进行Meta分析,证据确定性从极低到高不等,需进一步研究确定最优治疗。
要点
- 三联组合霜及其成分氢醌和维A酸对黄褐斑有提亮效果。
- 广谱防晒覆盖可见光和紫外线可增强氢醌的疗效。
- 多数试验样本量小、结局指标差异大,进一步研究需确定最优治疗。
核心结论
- 三联组合霜及其成分氢醌和维A酸对黄褐斑有提亮效果。
- 除已确立的自我应用治疗外,还发现其他医学治疗以及有前景的化妆和草药产品方法。
- 证据提示使用覆盖可见光和紫外线的广谱防晒可增强氢醌的疗效。
- 由于多数直接比较的随机对照试验样本量小且结局指标广泛,需进一步研究以得出哪种治疗最有效的结论。
研究设计与样本
- 系统检索MEDLINE和Cochrane CENTRAL试验数据库,纳入研究者盲法随机对照试验,研究对象为诊断为黄褐斑并接受自我应用局部干预的患者。
- 纳入标准限于方法学部分明确说明随机分配序列生成方式且研究结局评估者对分组设盲的随机对照试验。
- 共检索到1078条记录,纳入36项研究,报告47种不同干预比较。
- 感兴趣结局包括评估者评估的临床评分(如黄褐斑面积和严重程度指数)、生活质量和患者报告结局以及安全性结局。
- 采用GRADE方法评估效应估计的确定性。
主要发现
- 仅两项比较可进行数据合并:局部氨甲环酸 vs 氢醌,以及半胱胺 vs 安慰剂。
- 多种干预有直接比较,但报告结局差异很大。
- 对效应估计的确定性总体从极低到高不等。
关键数值与推荐
- 三联组合霜及其成分氢醌和维A酸对黄褐斑有提亮效果。
- 证据提示覆盖可见光和紫外线的广谱防晒可增强氢醌的疗效。
- 仅局部氨甲环酸 vs 氢醌和半胱胺 vs 安慰剂两项比较可进行Meta分析。
临床怎么用
- 原文未据此给出推荐。
局限性
- 多数直接比较治疗的随机对照试验样本量小且使用广泛结局指标,需进一步研究以得出哪种治疗最有效的结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Melasma is a common dermatological condition. Although its relevance as a skin condition is primarily of a cosmetic nature, it may affect the patient's wellbeing and quality of life. A broad range of treatment options is available, which makes it difficult to choose the most appropriate of those treatments. OBJECTIVES: To summarize and critically appraise evidence from investigator-blinded randomized controlled trials (RCTs) on the efficacy and safety of self-applied topical interventions for melasma. METHODS: We systematically searched MEDLINE and the Cochrane CENTRAL trials database for RCTs on topical, self-administered interventions for patients diagnosed with melasma. Eligibility was limited to RCTs that explicitly stated in their methods section (i) how they generated the random allocation sequence, and (ii) that the study outcome assessor was blinded to the participants' group allocation. Outcomes of interest included evaluator-assessed clinical scores (such as the Melasma Area and Severity Index), quality of life and patient-reported outcomes, as well as safety outcomes. The study findings were meta-analysed, pooling data from studies on the same comparisons, if this was possible. We assessed confidence in effect estimates using the GRADE approach. RESULTS: Our searches yielded 1078 hits. We included 36 studies reporting on 47 different comparisons of interventions. These included medical treatments such as 'triple combination cream' (TCC), over-the-counter cosmetic and herbal products, as well as sun creams covering different light spectra. Pooling data was possible for only two comparisons, topical tranexamic acid (TXA) vs. hydroquinone (HQ) and cysteamine vs. placebo. Direct comparisons were available for a variety of interventions; however, the reported outcomes varied greatly. Overall, our confidence in the effect estimates ranged from very low to high. CONCLUSIONS: Our findings indicate that TCC and its individual components HQ and tretinoin are effective in lightening melasma. Besides these established self-applied treatment options, we identified further medical treatments as well as promising cosmetic and herbal product treatment approaches. Furthermore, evidence suggests that using broad-spectrum sunscreen covering both the visible and ultraviolet-light spectrum enhances the treatment efficacy of HQ. However, with mostly small RCTs comparing treatments directly using a broad range of outcomes, further research is needed to draw conclusions about which treatment is most effective. What is already known about this topic? Melasma is a common dermatological disease. Although it is primarily a cosmetic condition, it can severely affect the patient's wellbeing and quality of life. Treatment options for melasma include a broad range of medical, cosmetic and herbal products. Given the large number of available interventions, it is difficult for clinicians and for patients to make informed decisions about which treatment to choose. What does this study add? We systematically assessed data from investigator-blinded randomized controlled trials of self-applied topical interventions. Our GRADE evaluations of confidence in the findings ranged from very low to high and may help clinicians and patients navigate treatment decisions. Besides the established self-applied medical treatment options, we identified promising cosmetic and herbal treatment approaches. Evidence suggests sunscreen covering the ultraviolet (UV)- and visible light spectra increases treatment efficacy compared with UV-only protection.
引用
- Pennitz A, Kinberger M, Avila Valle G, et al. Self-applied topical interventions for melasma: a systematic review and meta-analysis of data from randomized, investigator-blinded clinical trials. Br J Dermatol. 2022. PMID: 35290681. doi:10.1111/bjd.21244
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。